Sharon MacLachlan
Sharon MacLachlan publishes mostly in Neurology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, on topics such as Myasthenia Gravis and Thymoma, Parkinson's Disease and Spinal Disorders and Potassium and Related Disorders.
- World rank
- #2,157,074 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #156,523 of 367,258
- Works
- 38
- Citations
- 643
- Citations per work
- 16.9
What does Sharon MacLachlan research?
Sharon MacLachlan's work is mostly in Medicine (59%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2259.1%
- Medicine2259.1%
- Everything else1640.9%
- 1Neurology16% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Endocrinology, Diabetes and Metabolism9% of their works
- 4Epidemiology8% of their works
- 5Surgery6% of their works
- 6Physiology4% of their works
Research topics
- Myasthenia Gravis and Thymoma
- Parkinson's Disease and Spinal Disorders
- Potassium and Related Disorders
- Diabetes Treatment and Management
- Chronic Disease Management Strategies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Botulinum Toxin and Related Neurological Disorders
- Multiple Sclerosis Research Studies
Which keywords describe Sharon MacLachlan's research?
The keywords of their largest research topics: Epidemiology, Heart Failure, Neurological Disorders, Camptocormia, Hyperkalemia, Myasthenia Gravis, Parkinson's Disease and Renin-Angiotensin-Aldosterone System Inhibitors.
- Multiple Sclerosis
- Botulinum Toxin
- Type 2 Diabetes
- Chronic Conditions
- COPD
- Renin-Angiotensin-Aldosterone System Inhibitors
- Myasthenia Gravis
- Camptocormia
- Heart Failure
- Epidemiology
- Neurological Disorders
- Hyperkalemia
- Parkinson's Disease
- Thymic Tumors
- Cardiovascular Outcomes
- Multimorbidity
- spirometry
- Diagnostic Criteria
- Neurotoxins
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Epidemiology92 topics
- Heart Failure92 topics
- Neurological Disorders82 topics
- Camptocormia51 topic
- Hyperkalemia51 topic
- Myasthenia Gravis51 topic
- Parkinson's Disease51 topic
- Renin-Angiotensin-Aldosterone System Inhibitors51 topic
- Thymic Tumors51 topic
- COPD41 topic
- Cardiovascular Outcomes41 topic
- Chronic Conditions41 topic
- Multimorbidity41 topic
- Type 2 Diabetes41 topic
- spirometry41 topic
- Botulinum Toxin31 topic
- Diagnostic Criteria31 topic
- Multiple Sclerosis31 topic
- Neurotoxins31 topic
Where does Sharon MacLachlan work?
Sharon MacLachlan's main affiliation in the publication record is EVRAZ (United Kingdom), United Kingdom.
How many publications and citations does Sharon MacLachlan have?
OpenAlex counts 38 works and 643 citations for Sharon MacLachlan, an h-index of 12, ranking #2,157,074 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sharon MacLachlan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.